Neutrophils Promote Larynx Squamous Cell Carcinoma Progression via Activating the IL-17/JAK/STAT3 Pathway

Laryngeal squamous cell carcinoma (LSCC) is the main type of laryngeal cancer with poor prognosis. Incidence of LSCC increases every year, posing a great threat to human health. The underlying mechanism needs further study. Neutrophils are the most prevalent type of immune cells, which play vital ro...

Full description

Saved in:
Bibliographic Details
Main Authors: Tianyi Liu, Shimin Zong, Yang Jiang, Rui Zhao, Jie Wang, Qingquan Hua
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2021/8078646
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832545967310635008
author Tianyi Liu
Shimin Zong
Yang Jiang
Rui Zhao
Jie Wang
Qingquan Hua
author_facet Tianyi Liu
Shimin Zong
Yang Jiang
Rui Zhao
Jie Wang
Qingquan Hua
author_sort Tianyi Liu
collection DOAJ
description Laryngeal squamous cell carcinoma (LSCC) is the main type of laryngeal cancer with poor prognosis. Incidence of LSCC increases every year, posing a great threat to human health. The underlying mechanism needs further study. Neutrophils are the most prevalent type of immune cells, which play vital roles in crosstalk between the microenvironment and cancer cells. In our study, we aim to figure out the complex regulation between neutrophils and LSCC. Our experiments showed that LSCC cells could promote the activation and mobility of neutrophils. And, in return, neutrophils enhanced the proliferation, migration, and invasion of LSCC. The subsequent results showed that IL-17 was highly expressed in neutrophil conditioned medium. Block of IL-17 could effectively inhibit the progression of LSCC induced by neutrophils. What is more, the results showed that IL-17 activated the JAK/STAT3 pathway in LSCC. Inhibition of the JAK/STAT3 pathway could significantly block neutrophil-induced LSCC progression. Our research reveals the complex interaction between neutrophils and LSCC cells, providing new ideas for the treatment of LSCC.
format Article
id doaj-art-06008469380f4fdba48145a2c0f88324
institution Kabale University
issn 2314-7156
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-06008469380f4fdba48145a2c0f883242025-02-03T07:24:15ZengWileyJournal of Immunology Research2314-71562021-01-01202110.1155/2021/8078646Neutrophils Promote Larynx Squamous Cell Carcinoma Progression via Activating the IL-17/JAK/STAT3 PathwayTianyi Liu0Shimin Zong1Yang Jiang2Rui Zhao3Jie Wang4Qingquan Hua5Department of OtorhinolaryngologyDepartment of OtorhinolaryngologyDepartment of OtorhinolaryngologyDepartment of OtorhinolaryngologyDepartment of OtorhinolaryngologyDepartment of OtorhinolaryngologyLaryngeal squamous cell carcinoma (LSCC) is the main type of laryngeal cancer with poor prognosis. Incidence of LSCC increases every year, posing a great threat to human health. The underlying mechanism needs further study. Neutrophils are the most prevalent type of immune cells, which play vital roles in crosstalk between the microenvironment and cancer cells. In our study, we aim to figure out the complex regulation between neutrophils and LSCC. Our experiments showed that LSCC cells could promote the activation and mobility of neutrophils. And, in return, neutrophils enhanced the proliferation, migration, and invasion of LSCC. The subsequent results showed that IL-17 was highly expressed in neutrophil conditioned medium. Block of IL-17 could effectively inhibit the progression of LSCC induced by neutrophils. What is more, the results showed that IL-17 activated the JAK/STAT3 pathway in LSCC. Inhibition of the JAK/STAT3 pathway could significantly block neutrophil-induced LSCC progression. Our research reveals the complex interaction between neutrophils and LSCC cells, providing new ideas for the treatment of LSCC.http://dx.doi.org/10.1155/2021/8078646
spellingShingle Tianyi Liu
Shimin Zong
Yang Jiang
Rui Zhao
Jie Wang
Qingquan Hua
Neutrophils Promote Larynx Squamous Cell Carcinoma Progression via Activating the IL-17/JAK/STAT3 Pathway
Journal of Immunology Research
title Neutrophils Promote Larynx Squamous Cell Carcinoma Progression via Activating the IL-17/JAK/STAT3 Pathway
title_full Neutrophils Promote Larynx Squamous Cell Carcinoma Progression via Activating the IL-17/JAK/STAT3 Pathway
title_fullStr Neutrophils Promote Larynx Squamous Cell Carcinoma Progression via Activating the IL-17/JAK/STAT3 Pathway
title_full_unstemmed Neutrophils Promote Larynx Squamous Cell Carcinoma Progression via Activating the IL-17/JAK/STAT3 Pathway
title_short Neutrophils Promote Larynx Squamous Cell Carcinoma Progression via Activating the IL-17/JAK/STAT3 Pathway
title_sort neutrophils promote larynx squamous cell carcinoma progression via activating the il 17 jak stat3 pathway
url http://dx.doi.org/10.1155/2021/8078646
work_keys_str_mv AT tianyiliu neutrophilspromotelarynxsquamouscellcarcinomaprogressionviaactivatingtheil17jakstat3pathway
AT shiminzong neutrophilspromotelarynxsquamouscellcarcinomaprogressionviaactivatingtheil17jakstat3pathway
AT yangjiang neutrophilspromotelarynxsquamouscellcarcinomaprogressionviaactivatingtheil17jakstat3pathway
AT ruizhao neutrophilspromotelarynxsquamouscellcarcinomaprogressionviaactivatingtheil17jakstat3pathway
AT jiewang neutrophilspromotelarynxsquamouscellcarcinomaprogressionviaactivatingtheil17jakstat3pathway
AT qingquanhua neutrophilspromotelarynxsquamouscellcarcinomaprogressionviaactivatingtheil17jakstat3pathway